|
cialis tadalafil Mplates MenuPageDrugInfo.htm --> Cialis (tadalafil) Information Page BODY .header .footer .pagetitle FDA Home Page CDER Home Page CDER Site Info Contact CDER What's New @ CDER Search Cialis (tadalafil) FDA ALERT 07 2005 : A small number of men have lost eyesight in one eye some time after taking Cialis cialis tadalafil, Viagra cialis tadalafil, or Levitra. This type of vision loss is called non-arteritic anterior ischemic optic neuropathy (NAION). NAION causes a sudden loss of eyesight because blood flow is blocked to the optic nerve. We do not know at this time if Cialis cialis tadalafil, Viagra or Levitra causes NAION. NAION also happens in men who do not cialis tadalafil.
cialis tadalafil take these medicines. People who have a higher chance for NAION include those who: have heart disease are over 50 years old have diabetes have high blood pressure have high cholesterol smoke have certain eye problems FDA has approved new labels for Cialis cialis tadalafil, Viagra cialis tadalafil, and Levitra to include information on possible eyesight loss (NAION). Stop using Cialis cialis tadalafil, Viagra cialis tadalafil, or Levitra if you have a loss in your eyesight. Get medical help right away. Current Information Patient Information Sheet PDF HTML Healthcare Professional Sheet PDF HTML FDA Statement Label (7 8 2005) Background Information FDA has approved Cialis for the treatment of men who experience difficulty having and maintaining an erection (impotence). Although there are other drugs on the market for this indication cialis tadalafil, this drug is different in that it may work up to 36 hours after dosing. FDA Talk Paper Cialis Label (3 31 2005) Cialis Patient Package Insert Cialis Approval Letter Questions and Answers for Cialis Back to Drug Information Date created: November 21 cialis tadalafil, 2003 cialis tadalafil, Updated cialis tadalafil, July 8 cialis tadalafil, 2005 CDER Home Page CDER Site Info Contact CDER What's New @ CDER FDA Home Page Search FDA Site FDA A-Z Index Contact FDA HHS Home Page FDA Center for Drug Evaluation and Research.
cialis tadalafil the treatment of men who experience difficulty having and maintaining an erection (impotence). Although there are other drugs on the market for this indication cialis tadalafil, this drug is different in that it may work up to 36 hours after dosing. FDA Talk Paper Cialis Label (3 31 2005) Cialis Patient Package Insert Cialis Approval Letter Questions and Answers for Cialis Back to Drug Information Date created: November 21 cialis tadalafil, 2003 cialis tadalafil, Updated cialis tadalafil, July 8 cialis tadalafil, 2005 CDER Home Page CDER Site Info Contact CDER What's New @ CDER FDA Home Page Search FDA Site FDA A-Z Index Contact FDA HHS Home Page FDA Center for Drug Evaluation and Research .
cialis tadalafil 
cialis tadalafil | | | | | |
cialis tadalafil
|
